Ascentage Pharma Group International (AAPG) Total Return Calculator with Dividends Reinvested

Ascentage Pharma Group International

Popular:

The total return for Ascentage Pharma Group International (AAPG) stock is -56.98% over the past 12 months. So far it's down 35.23% this year. The 5-year total return is -1.73%, meaning $10,000 invested in AAPG stock 5 years ago would be worth $9,827 today. Total return includes price appreciation plus reinvesting any dividends paid out.

If you invested $10,000 in AAPG 1 year ago, it would be worth $4,259 today — you'd have lost $5,741.

With Dividends Reinvested$4,259-57.41%

Price Only (No DRIP)$4,259-57.41%

Period2025-06-30 → 2026-06-26

Price

Total Return (DRIP)

S&P 500

If You Invested $10,000 in AAPG

1Y$4,302-$5,698 (-57.0%)-57.0% CAGR

3Y$9,827-$173 (-1.7%)-0.6% CAGR

5Y$9,827-$173 (-1.7%)-0.3% CAGR

10Y$9,827-$173 (-1.7%)-0.2% CAGR

15Y$9,827-$173 (-1.7%)-0.1% CAGR

20Y$9,827-$173 (-1.7%)-0.1% CAGR

30Y$9,827-$173 (-1.7%)-0.1% CAGR

Ascentage Pharma Group International did not pay dividends during this period. Total return = price return.

Loading AAPG total return...

As of 2026-06-28

Performance Summary

Best Year+50.98%2025

Max Drawdown-64.99%2025-08-22 → 2026-06-16

Period	Total Return	CAGR	Price Only	Div. Contrib.	$10K →
YTD	-35.23%	—	-36.41%	+1.18 pp	$6,477
1Y	-56.98%	-56.98%	-58.91%	+1.93 pp	$4,302
3Y	-1.73%	-0.58%	-3.51%	+1.78 pp	$9,827
5Y	-1.73%	-0.35%	-3.51%	+1.78 pp	$9,827
10Y	-1.73%	-0.17%	-3.51%	+1.78 pp	$9,827
15Y	-1.73%	-0.12%	-3.51%	+1.78 pp	$9,827
20Y	-1.73%	-0.09%	-3.51%	+1.78 pp	$9,827
30Y	-1.73%	-0.06%	-3.51%	+1.78 pp	$9,827

Annual Returns

Year	Total Return	Price Return	Div.	S&P 500	vs S&P
2026YTD	-8.99%	-8.99%	—	+0.41%	-9.4pp
2025	+50.98%	+50.98%	—	+16.64%	+34.3pp

AAPG underperformed the S&P 500 by 77.82pp over the past year (-56.98% vs +20.84%).

Loading summary...

AAPG Peers' Total Return

Accurate peer set · 10 comparable names

Name	Mkt Cap	30D Rtn	YTD Total Rtn	1Y Total Rtn	Div Contrib	3Y Total Rtn	5Y Total Rtn	10Y Total Rtn
AAPGAscentage Pharma Group International	$1.6B	-16.7%	-35.2%	-57.0%	—	-1.7%	-1.7%	-1.7%
ABBVAbbVie Inc.	$444.4B	+18.0%	+3.9%	+30.2%	+3.6pp	+88.3%	+131.2%	+374.7%
BCABBioAtla, Inc.	$5M	-9.1%	-85.8%	-80.8%	—	-97.6%	-99.8%	-99.8%
KYMRKymera Therapeutics, Inc.	$8.8B	+33.9%	+37.3%	+111.9%	—	+342.1%	+125.5%	+200.3%
ARVNArvinas, Inc.	$516M	-10.3%	-29.8%	+4.0%	—	-69.0%	-89.4%	-49.8%
IMVTImmunovant, Inc.	$8.0B	+14.8%	+47.5%	+138.9%	—	+98.5%	+247.5%	+284.1%
GILDGilead Sciences, Inc.	$158.8B	-4.4%	+4.3%	+19.7%	+3.0pp	+75.7%	+108.9%	+89.3%
BMYBristol-Myers Squibb Company	$117.4B	-0.9%	+5.2%	+22.3%	+5.3pp	-3.9%	+1.1%	+6.1%
JAZZJazz Pharmaceuticals plc	$14.4B	-3.1%	+32.7%	+112.6%	—	+83.8%	+28.6%	+66.7%
ACADACADIA Pharmaceuticals Inc.	$4.3B	+19.1%	-10.7%	+4.2%	—	-2.1%	-6.6%	-25.7%
PTCTPTC Therapeutics, Inc.	$7.0B	+24.8%	+10.0%	+70.1%	—	+108.9%	+91.2%	+1167.4%

Compare:AAPG vs ABBV AAPG vs BCAB AAPG vs KYMR AAPG vs ABBV vs BCAB

About AAPG Dividend Returns

Ascentage Pharma Group International (AAPG) does not currently pay dividends. Many growth-focused companies reinvest profits back into the business rather than distributing them as dividends.

How We Calculate Total Return

Our total return calculator simulates dividend reinvestment (DRIP) by assuming each dividend payment is used to purchase additional shares at the closing price on the ex-dividend date. This methodology provides an accurate representation of how a dividend reinvestment plan would perform.

Frequently Asked Questions

Q1What is the total return of AAPG over the past year?

Ascentage Pharma Group International (AAPG) delivered a return of -56.98% over the past year. Since AAPG does not currently pay dividends, the total return equals the price-only return.

Q2How much would $10,000 invested in AAPG be worth today?

A $10,000 investment in Ascentage Pharma Group International one year ago would be worth $4,302 today, representing a loss of $5,698.

Q3Does AAPG pay dividends?

Ascentage Pharma Group International (AAPG) does not currently pay dividends. Many growth-focused companies reinvest profits back into the business rather than distributing them as dividends. For AAPG, the total return equals the price-only return.

Q4Did AAPG beat the S&P 500?

No, Ascentage Pharma Group International (AAPG) underperformed the S&P 500 by 77.82 percentage points over the past year. AAPG delivered a total return of -56.98%, compared to the S&P 500's 20.84%. This means a passive S&P 500 index fund outperformed AAPG by 77.82pp during this period.

Q5What is AAPG's worst drawdown?

Ascentage Pharma Group International (AAPG) experienced a maximum drawdown of -64.99% over the past year, declining from its peak on 2025-08-22 to its trough on 2026-06-16. The stock has not yet fully recovered to its prior peak. Maximum drawdown measures the worst peak-to-trough decline and is an important risk metric for investors.

Q6What is AAPG's long-term total return over 10, 20, or 30 years?

Here are Ascentage Pharma Group International (AAPG)'s long-term returns with dividends reinvested. Over 10 years, the total return is -1.7% (-0.2% CAGR) — $10,000 would have grown to $9,827. Over 20 years: -1.7% total return (-0.1% CAGR) — $10,000 → $9,827. Over 30 years: -1.7% total return (-0.1% CAGR) — $10,000 → $9,827. Long-term investors benefit from compounding: dividends buy additional shares, which generate their own dividends, creating an exponential growth effect.

How much would $100/month in AAPG be worth today?

Dollar cost averaging calculator · DCA vs lump sum · see how regular investing compounds

Run the Numbers →